ArticleHepatobiliary surgery and nutrition2020

Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma.

Jianzhen Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.